The Filing Desk

Pharming Group vs Sinovac Biotech

Pharming Group PHAR · Sinovac Biotech SVA · Pharmaceuticals

Sinovac Biotech reported revenue of $386 million in fiscal 2025, about the same as Pharming Group's $376 million in fiscal 2025. Pharming Group's revenue grew 26.6% in its latest year, and Sinovac Biotech's grew 6.8%. Pharming Group had an operating margin of 6.9%, against -127.0% at Sinovac Biotech. Free cash flow was $54 million at Pharming Group and −$561 million at Sinovac Biotech.

Side by side

Pharming GroupSinovac Biotech
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$376M$386M
Revenue growth26.6%6.8%
Revenue growth a year, last 5 years12.1%−5.4%
Gross margin87.9%67.9%
Operating margin6.9%−127.0%
Net margin0.8%−51.5%
Free cash flow$54M−$561M
Free cash flow margin14.3%−145.4%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$3.5B
Change in diluted share count−4.9%0.0%
Last close$12.17—
P/E at the last close——
Insider trades, last 12 months——
Piotroski F-score—3 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Pharming GroupSinovac Biotech
Operating margin
Percent of revenue
Pharming GroupSinovac Biotech
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Pharming GroupSinovac Biotech

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Pharming Group and Sinovac Biotech pages.